Browsing Pharmacy, College of by Subject "venous thromboembolism"
Now showing items 1-1 of 1
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran. (Dove Medical Press, 2015-07-09)Venous thromboembolism includes deep vein thrombosis and pulmonary embolism and is a serious medical condition that requires anticoagulation as part of treatment. Currently, standard therapy consists of parenteral ...